Ambu AS (OTCPK:AMBFF)
$ 19.9 -0.6 (-2.93%) Market Cap: 4.15 Bil Enterprise Value: 4.24 Bil PE Ratio: 130.11 PB Ratio: 5.45 GF Score: 96/100

Q1 2024 Ambu A/S Earnings Call Transcript

Jan 30, 2024 / 10:00AM GMT
Release Date Price: $15.6
Britt Meelby Jensen;S;CEO;Member of the Executive Board
Ambu A

/-&

Good morning, everyone, and welcome to this earnings call this morning, where we will report on Ambu's first-quarter results in our fiscal-year 2023-24. My name is Britt Meelby Jensen, and it's a pleasure for me to welcome our new CFO, Henrik Skak Bender, who joined us January 1, to lead our Finance, Legal, and IT function as our Chief Financial Officer.

For the agenda today, Henrik and I will first go through our financial results. I'll present the business update and hand over to Henrik for the financials, and then, we will finish the call with a Q&A session.

So starting with the highlights of the business. We are off to a strong start for our first quarter this year with a 14% organic revenue growth hereof at 25% growth in our key business area, our Endoscopy Solutions area, compared to 3% in Endoscopy last year. This strong revenue growth is partly the reason why we also can report a strong EBIT margin before special items of 10% for the quarter compared to 6%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot